Jinhe Biotechnology CO., LTD. (SHE:002688)
5.81
-0.36 (-5.83%)
Mar 20, 2026, 3:04 PM CST
SHE:002688 Market Cap
SHE:002688 has a market cap or net worth of 4.64 billion as of March 20, 2026. Its market cap has increased by 40.06% in one year.
Market Cap
4.64B
Enterprise Value
6.59B
Revenue
2.75B
Ranking
n/a
PE Ratio
37.80
Stock Price
5.81
Market Cap Chart
Since July 13, 2012, SHE:002688's market cap has increased from 2.51B to 4.64B, an increase of 84.92%. That is a compound annual growth rate of 4.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 4.37B | -2.35% |
| Dec 31, 2025 | 4.48B | 32.34% |
| Dec 31, 2024 | 3.38B | -6.73% |
| Dec 29, 2023 | 3.63B | -6.42% |
| Dec 30, 2022 | 3.87B | -19.02% |
| Dec 31, 2021 | 4.78B | 37.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Newland Pharmaceutical | 4.92B |
| Zhejiang Yatai Pharmaceutical | 4.91B |
| Jianmin Pharmaceutical Group | 4.90B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 4.74B |
| Tibet Weixinkang Medicine | 4.73B |
| Yabao Pharmaceutical Group | 4.63B |
| Jinling Pharmaceutical Company | 4.61B |
| LanZhou Foci Pharmaceutical | 4.58B |